These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Fenofibrate, efficacy and tolerance in long-term treatment (author's transl)]. Fromantin M, Gautier D, Quatre JM, Bon R. Therapie; 1981 Nov; 36(4):473-6. PubMed ID: 7292431 [No Abstract] [Full Text] [Related]
3. Drug treatment of hyperlipoproteinaemia. Romics L. Ther Hung; 1983 Nov; 31(4):152-60. PubMed ID: 6400456 [No Abstract] [Full Text] [Related]
4. [Differential therapy of hyperlipoproteinemias]. Zegenhagen R. Z Arztl Fortbild (Jena); 1990 Nov; 84(21):1093-4. PubMed ID: 2281694 [No Abstract] [Full Text] [Related]
5. [Hyperlipoproteinemias: experience of out-patient treatment of 112 patients (author's transl)]. Arteaga A, Maiz A, Lathrop R. Rev Med Chil; 1981 Oct; 109(10):945-51. PubMed ID: 7344018 [No Abstract] [Full Text] [Related]
6. [Antilipemic drugs]. Schwandt P. Med Monatsschr Pharm; 1980 Oct; 3(10):302-5. PubMed ID: 7007844 [No Abstract] [Full Text] [Related]
7. [Dyslipoproteinemia of diabetes: fibrates or statins?]. Moulin P. Diabetes Metab; 1999 Sep; 25(3):270-4. PubMed ID: 10499198 [No Abstract] [Full Text] [Related]
8. [Evaluation of the effects of tiadenol in various types of dyslipidemia]. Saettone G, Cazzani E, Romanò M, Muzio L. Clin Ter; 1982 May 31; 101(4):387-93. PubMed ID: 7105643 [No Abstract] [Full Text] [Related]
9. [Drug treatment of hyperlipoproteinemia]. Chanu B. Soins; 1987 Jul 31; (502):21-6. PubMed ID: 3672153 [No Abstract] [Full Text] [Related]
10. Current status of drugs used to treat hyperlipoproteinemias. Saunders RN, Azarnoff DL. Drug Ther; 1982 Jul 31; ():1-16. PubMed ID: 7049648 [No Abstract] [Full Text] [Related]
11. [Drug therapy of hyperlipoproteinemias]. Dalmau Serra J. An Esp Pediatr; 1991 Oct 31; 35 Suppl 45():20-1. PubMed ID: 1763865 [No Abstract] [Full Text] [Related]
12. [Drug therapy of hyperlipoproteinemia]. Steinmetz A, Kaffarnik H. Internist (Berl); 1992 Jan 31; 33(1):44-53. PubMed ID: 1551763 [No Abstract] [Full Text] [Related]
14. [Evaluation of a sulfomucopolysaccharide (3GS) in the treatment of hyperlipoproteinemias]. Palmieri G, Perego M, Nazzari M, Casalini F. Clin Ter; 1982 Jun 30; 101(6):603-14. PubMed ID: 7128029 [No Abstract] [Full Text] [Related]
15. [The role of hypolipidaemic agents in the fight against atherosclerosis (author's transl)]. Jacotot B. Nouv Presse Med; 1980 Oct 30; 9(40):2951-4. PubMed ID: 7443429 [No Abstract] [Full Text] [Related]
16. [Lipid lowering therapy in the elderly]. Kaffarnik H, Schneider J. MMW Munch Med Wochenschr; 1983 Jul 15; 125(28):663-5. PubMed ID: 6412133 [No Abstract] [Full Text] [Related]
17. [A study of the effect of some hypolipidemic substances]. Synková J. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1978 Jul 15; 21(4):401-25. PubMed ID: 316922 [No Abstract] [Full Text] [Related]
18. [Clinical pharmacology of antilipemic agents]. Cuena Boy R, Azanza Perea JR, Honorato Pérez J. Rev Med Univ Navarra; 1983 Mar 15; 27(1):25-8. PubMed ID: 6669829 [No Abstract] [Full Text] [Related]
19. [Present status of fibrates in the treatment of hyperlipoproteinemias]. Soska V. Vnitr Lek; 1999 Jul 15; 45(7):438-40. PubMed ID: 11045165 [Abstract] [Full Text] [Related]
20. [On the article by Dr. R. Ceska, et al: Fenofibrat Pharmavit SR 250 in patients with mixed hyperlipoproteinemia]. Mayer O. Cas Lek Cesk; 2001 Mar 29; 140(6):188-9. PubMed ID: 11347210 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]